Why the study?
Recent advances in receptor imaging, screening methods, and homology modeling have stimulated exploration of orthosteric and allosteric P2Y receptor antagonists, prompting an updated assessment of compounds published since 2016.
Answers are grounded in this paper and cite their sources.
Provides an updated perspective on recently discovered P2Y receptor antagonists with potential for clinical development.
receptors and homology modeling has stimulated research groups to explore orthosteric and allosteric receptor antagonists, aided in part by the discovery of fluorescent P2YR imaging tools and sensitive screening methods that allow the identification of low affinity P2Y receptor antagonists. This Perspective critically assesses P2Y receptor antagonists published since 2016, highlighting potential oral lead- or drug-like compounds that offer opportunities for the development of molecules for clinical evaluation.
No takes yet. Share an insight, caveat, or question.
Puthanveedu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: